The California State Athletic Commission voted today to reduce Chael Sonnen’s one-year suspension to six months by a 3-to-1 vote. Sonnen had failed his UFC 117 drug test, where he registered higher than normal levels of testosterone following his title fight loss to champion Anderson Silva this past August.
Sonnen revealed during today’s hearing that he had been undergoing testosterone replacement therapy due to hypogonadism, which require he take regular doses of testosterone. Although TRT is allowed, a competitor must provide sufficient evidence of its necessity and thereby clear it with each state athletic commission prior to each bout before which TRT was undergone.
Sonnen noted that he had informed George Todd, the commission’s executive officer, of his condition. Dodd confirmed Sonnen’s claim and stated that while Sonnen had informed him of his condition, he failed to file the necessary paperwork.
According to MMAFighting, Sonnen did list “1 shot” of testosterone under the section of the urine sample form that asks what medications or substances, if any, have been recently ingested by the athlete. In addition to the testosterone shot, Sonnen listed varying doses of Aspirin, multivitamins, vitamin C, iron and Advil as substances he had recently ingested.
After reviewing Sonnen’s urine sample, it was found that his epitestosterone level was much higher than that which is naturally found in the human body; Sonnen’s sample registered at 16.9, while the “threshold ratio” is 4.0.
Sonnen’s supension, which began on September 2, 2010, will now run until March 2, 2011. His $2,500 fine remains intact.
Thanks to Mark Wayne for contributing to this article.